Condition 101 About Apolipoprotein C2 Deficiency

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Apolipoprotein C2 Deficiency

View All Doctors

Latest Advances On Apolipoprotein C2 Deficiency

  • Condition: Severe Hypertriglyceridemia
  • Journal: Cardiovascular diabetology
  • Treatment Used: Pemafibrate
  • Number of Patients: 3
  • Published —
This study reported on patients with severe hypertriglyceridemia (high blood triglycerides) who were treated with pemafibrate.
  • Condition: Familial Chylomicronemia Syndrome (FCS) or Hypertriglyceridemia
  • Journal: Drug design, development and therapy
  • Treatment Used: Volanesorsen
  • Number of Patients: 0
  • Published —
This article discusses volanesorsen in the treatment of familial chylomicronaemia syndrome (FCS), a rare disorder of lipid metabolism characterized by high levels of triglycerides (TGs).
View All Latest Advances

Clinical Trials For Apolipoprotein C2 Deficiency

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: November 18, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Drug, Dietary Supplement
  • Participants: 16
  • Start Date: December 9, 2019
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
View All Clinical Trials